Back to all Programs

Register here

Related Materials

Past event

European Meeting on HIV & Hepatitis 2020

Viral Hepatitis and Liver Disease

Charles Flexner - Patients with Poor or Good Adherence

Viral Hepatitis and Liver Disease

Cancer, archived resistance mutations - Romain Palich

Viral Hepatitis and Liver Disease

Clinical Aspects - Prof Milosz Parczewski

Viral Hepatitis and Liver Disease

Clinical Relevance of Diagnostic Testing - Carlo Federico Perno

Viral Hepatitis and Liver Disease

First Day Treatment, Definition - Dr Paul Sax

Viral Hepatitis and Liver Disease

HIV Pipeline - Kirsten White

Viral Hepatitis and Liver Disease

Implementing First Day Treatment in CEE - Prof. Milosz Parczewski

Viral Hepatitis and Liver Disease

Implementing First Day Treatment - Margaret Johnson

Viral Hepatitis and Liver Disease

Jade Ghosn - Andrea De Luca Lecture

Viral Hepatitis and Liver Disease

Management of the COVID 19 Pandemic in Europe - Diagnostics - Ravindra Gupta

Viral Hepatitis and Liver Disease

Overview of the current situation regarding PrEP and resistance - Daniel Kuritzkes

Viral Hepatitis and Liver Disease

Resistance to Long - Acting Antivirals - Anne-Genevieve Marcelin

Viral Hepatitis and Liver Disease

Physiopathology and Treatment - Xavier Lescure

Viral Hepatitis and Liver Disease

Social Aspects - Michael Meulbroek

Viral Hepatitis and Liver Disease

Testing for Hepatitis C Resistance - JM Pawlotsky

Viral Hepatitis and Liver Disease

Teymur Noori - Epidemiology of HIV and Hepatitis in CEE

Viral Hepatitis and Liver Disease

Treatment of Hepatitis B for HIV Clinicians - Anna-Maria Geretti

Viral Hepatitis and Liver Disease

Testing for Hepatitis C Resistance, Pro Standpoint - Francesca Ceccherini-Silberstein